51成人动漫

Cardiology >

Prevention

News, opinions and meeting coverage in cardiology.

Cancer-VTE Trial Falls Short

High dropout rate undermines rivaroxaban prophylaxis trial

The Most Wonderful Mistake the FDA Ever Made

Milton Packer explains how an FDA error enlightened the practice of medicine

FDA OKs Heart Disease Prevention Claim for High Oleic Acid Oils

Olive oil and certain other vegetable, seed oils get qualified health claim

Omega-3 and Vitamin D; Vein Grafts and CABG: It's PodMed Double T!

This week's topics include benefits of CABG, vein harvesting, new exercise guidelines, and omega-3 and vitamin D supplementation

Metabolic Surgery Prevails for Mortality, CV-Risk Reduction in T2D

Macrovascular complications, CV mortality reduced more with surgery than medical therapy alone

National Exercise Guidelines Now Say 'Just Move'

HHS recs say to sit less, move more to improve health outcomes

AHA: Rivaroxaban May Cut Thromboembolic Risk in HF Patients

Post hoc analysis of COMMANDER HF trial suggestive of benefit

AHA: Zetia May Cut CV Events in Japanese Seniors

Results from EWTOPIA75 trial not enough to change practice, experts says

AHA: In-hospital Entresto Safe, Beneficial in HFrEF

PIONEER-HF shows improved biomarkers and possibly outcomes too

AHA: Fish Oil, Vitamin D Not VITAL to Heart Health

VITAL trial also showed no benefits for cancer incidence with both supplements

AHA: Targeting Inflammation With Methotrexate Flops for CV Prevention

CIRT trial disappoints after CANTOS' win for the inflammatory hypothesis

AHA: Prescription Fish Oil Wins for CV Prevention

Positive findings for Vascepa in REDUCE-IT trial

AHA: Revised Lipid Guide Boosts PCSK9s, Coronary Calcium Scans

New recommendations aim to cut statins in low-risk primary prevention

Heart Benefit with Dulaglutide; New Hot Flash Therapy; Diabetes Risks in Women

News and commentary from the endocrinology world

AHA: Lipid Guidelines to Headline Meeting

Exercise, fish oil, Entresto in acute HF, and an anti-inflammatory also in the spotlight

AHA: Late Meals Linked to HTN, Prediabetes

Risks seen in study of Hispanic and Latino Americans

Expert Panel: Cap Oxygen Saturation at 96% for Acutely Ill Patients

Recommends special caution for stroke, MI patients

Case Study: Influenza Turned Lethal

Fulminant myocarditis claims life of otherwise healthy child

FDA Rejects Canakinumab in CVD Prevention

CANTOS data not enough to expand indication

Morning Break: Human Side of Addiction; Eyeing Da Vinci's Genius; No CV Indication for Ilaris

Health news and commentary from around the Web gathered by the 51成人动漫 staff

The Rest of the Story on Vitamin B for Stroke Prevention

J. David Spence, MD, digs into the developing rationale for a different kind of B

FDA Approves Rivaroxaban for CV Prevention in CAD, PAD

Low dose to arrive in the U.S. next week

NSAIDs OK for Certain High-Risk Groups?

No obvious harm seen in HTN, HF, or chronic kidney disease

Sandeep Jauhar's Real-Life Tales From, and of, the Heart

Exploring the organ's intertwined metaphorical and biological aspects

Withdrawn Diabetes Drug Worked in Secondary CV Prevention

Large cardiovascular outcomes trial showed a particular reduction in MI

Heart Benefit Seen with GLP-1 RA Albiglutide

Significant reduction in myocardial infarctions; will drug be brought back to market?

TCT: Near-Infrared Spectroscopy IDs Plaques Likely to Cause Problems

Non-culprit lesions with large lipid core associated with events

TCT: Stopping Antiplatelets 1 Year Post-Stent Risky for Afib Patients?

Underpowered trial suggested oral anticoagulation alone isn't enough

Vascepa Prevents Major Cardiovascular Events, Says Manufacturer

Big win for proprietary fish-oil product

TCT: Femoropopliteal Stents On Par in First Head-to-Head Trial

Primary patency, major adverse events at least as good with Eluvia as Zilver PTX

Macitentan Shows Promise in Portopulmonary Hypertension

Positive results in first randomized trial in the disease

Controlling BP Variability May Be Key to ICH Outcomes

Aggressive BP reduction alone has failed in the past

Aspirin, Fish Oil Disappoint in Primary CV Prevention

Two randomized trials suggest little to no net benefit

ESC: PURE Buries Controversy, Advocates for 'Balanced Diet'

But dairy and red meat levels still differ from guidelines

ESC: Interatrial Shunting Safe in HFpEF, Pivotal Trial to Come

Device eases left-sided filling pressure, but to what clinical significance?

ESC: Short DAPT with Ticagrelor Doesn't Improve Outcomes

Antiplatelet strategy safe, but misses superiority to standard DAPT after stenting

ESC: Aspirin Holds Little Net Benefit for Primary CV Prevention

'No compelling evidence' emerges in two randomized trials

ESC: Omega-3 Supplements No Better Than Olive Oil for CV Risk

1-g dose disappoints in ASCEND trial

ESC: Weight-Loss Drug Clears Major CV Hurdle

Trial also shows modest reduction in new cases of diabetes

ESC: Rivaroxaban Doesn't Prevent VTE after Acute Illness

Efficacy shown in prior trial is lost, but safety gained in this setting

鈥�

27

鈥�